Skip to content

Diurnal Variation of Tear Meniscus and Tear Osmolarity

Diurnal Variation of Tear Meniscus and Tear Osmolarity

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01206244
Enrollment
20
Registered
2010-09-21
Start date
2010-09-30
Completion date
2011-09-30
Last updated
2013-06-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry Eye

Keywords

dry eye, tear meniscus, tear osmolarity

Brief summary

This study is to determine the diurnal variation of tear meniscus and tear osmolarity in normal subjects and dry eye patients.

Detailed description

This study is to determine the diurnal variation of tear meniscus using OCT and tear osmolarity using Tearlab's osmolarity system in normal subjects and dry eye patients.

Interventions

None listed

Sponsors

Allergan
CollaboratorINDUSTRY
University of Miami
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Is at least 18 years old and has full legal capacity to volunteer; 2. Has read and signed the IRB Informed Consent Document; 3. Is willing and able to follow participant instructions; 4. Has clear corneas; 5. Has 20/100 uncorrected visual acuity or better; 6. Is not a hard (or rigid gas permeable) contact lens wearer within the last year; 7. Was a soft contact lens wearer, but stopped wearing at least 1 week ago; 8. Has dry eye according to the study definition of DES (study subjects).

Exclusion criteria

1. Has any systemic disease affecting ocular health except for Sjögren's syndrome; 2. Is using any systemic or topical medications that will affect ocular health except for artificial tears; 3. Has an active ocular disease other than DES, meibomian gland disease or Sjögren's syndrome 4. Has any clinically significant lid or conjunctival abnormalities, neovascularization, corneal scars or corneal opacities; 5. Has limbal or bulbar injection or corneal staining that was clinically significant, which are not due to DES; 6. Has worn rigid gas permeable lenses within 1 year; 7. Has had surgery or an eye injury within 6 months.

Design outcomes

Primary

MeasureTime frameDescription
Variations in tear osmolarity and tear meniscus volume in patients with dry eyes and in healthy control subjects over an 8-hr daytime period.8 hoursThe mean tear osmolarity of the dry eye patients was 304.0±10.8 mOsm/L, and the mean tear osmolarity of the normal subjects was 298.0±14.2 mOsm/L (P.0.05). Over the course of 8 hrs, the average measured osmolarities of the dry eye group varied by approximately 21.9±13.5 mOsm/L (range, 6-43 mOsm/L), and the average measured tear osmolarities of the normal group varied by approximately 21.0±9.2 mOsm/L (range, 8-35 mOsm/L). At 2:30 PM, the average volume of the tear menisci in the dry eye group was significantly lower than that of the subjects in the normal group (P,0.05). No correlations between the tear meniscus volumes and tear osmolarities of either group were observed.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026